Financhill
Back

Freeport-McMoRan, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison

Buy
75

FCX
Freeport-McMoRan, Inc.

Last Price:
$51.97
Seasonality Move:
7.92%
Buy
51

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$398.51
Seasonality Move:
2.83%
Buy
75
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $50.64. The Score for FCX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Alnylam Pharmaceuticals, Inc. (ALNY) is a Buy

Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $407.73. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $50.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals, Inc.'s stock price today?

  • The Alnylam Pharmaceuticals, Inc. share price today is $407.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.04 Buy
Relative Strength Index (14 RSI): 78.53 Buy
Chaikin Money Flow: 6185561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.09 - 47.67) Buy
Bollinger Bands (100): (39.72 - 45.44) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -14.68 Sell
Relative Strength Index (14 RSI): 41.22 Sell
Chaikin Money Flow: -134790 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (403.82 - 458.66) Sell
Bollinger Bands (100): (426.36 - 469.58) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.26 Buy
20-day SMA: 45.49 Buy
50-day SMA: 42.75 Buy
200-day SMA: 41.1 Buy
8-day EMA: 48.2 Buy
20-day EMA: 46.03 Buy
50-day EMA: 43.86 Buy
200-day EMA: 42.16 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 398.62 Buy
20-day SMA: 425.76 Sell
50-day SMA: 445.45 Sell
200-day SMA: 366.47 Buy
8-day EMA: 404.19 Buy
20-day EMA: 419.22 Sell
50-day EMA: 433.64 Sell
200-day EMA: 382.97 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.

Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.20 per share, and an increase next year of $6.23 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):